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Increased life expectancy in industrialized countries has
led to the progressive aging of the general population,
this event is associated with a concomitant increase of
Cardiovascular Disease (CVD) that represents not only
the main cause of death but also one of the major
causes of morbidity, inability and reduction of life qual-
ity in the elderly population.
In the Western countries, Arterial Hypertension (AH)
affects more than 50% of the elderly, and Heart Failure
(HF) represents the most frequent diagnosis among hos-
pital discharges among the elderly. The prevalence of
type 2 diabetes mellitus (DM) also increases in the
elderly population, reaching about the 7-10%. In this
context, the role of laboratory diagnostics is fundamen-
tal to support the diagnosis, for monitoring drug therapy
and its possible side effects. In patients with recent diag-
nosis of AI, it is crucial to perform a complete hemocro-
mocytometric analysis, the evaluation of lipid and
glucidic metabolism parameters, serum electrolytes, and
creatinine and uric acid to evaluate renal function.
Hemoglobin and hematocrit values can establish the
presence of anemia, which can be a sign of renal disease.
Fasting glucose can be used to define the diagnosis of
DM, and in patients with previous a diagnosis it is use-
ful to control the metabolic status that is correlated to
the development of cardiovascular complications. More-
over in hypertensive patients, the presence of high blood
glucose levels can mask a secondary form of AH, as do
the potassium serum levels. In addition, in the elderly
an impairment of the thyroid function should also be
evaluated, as a possible cause of atrial fibrillation, that is
the most frequent tachyarrhythmia in over 65 year olds.
Finally, the diagnosis of HF in the elderly with differ-
ent comorbidities can represent a very strong challenge;
in this case, laboratory diagnostics can support the
clinician in the diagnostic and therapeutic process. It is
advisable to measure BNP/NT-proBNP to exclude/con-
firm the diagnosis of HF in patients with ambiguous
clinical signs and symptoms that can be confused with
other clinical conditions. Moreover, it is important to
dose some laboratory parameters related to renal func-
tion to monitor possible side effects of drugs employed
in chronic HF (CHF). Thus, in the management of the
elderly affected by CVD, the laboratory is crucial and
the kind and the frequency of laboratory tests are above
all oriented by the patient’s clinical symptoms and signs,
by the presence of target organ damage and the possible
side effects of the employed drugs.
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